Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
about
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumorsPatient-derived tumour xenografts as models for oncology drug developmentEndocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsPatient-derived tumor xenografts: transforming clinical samples into mouse modelsPatient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic reviewMouse Models in Prostate Cancer Translational Research: From Xenograft to PDXMechanisms of oestrogen receptor (ER) gene regulation in breast cancerIn Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right PlatformBioengineering Models for Breast Cancer ResearchMicroRNA Regulation of Human Breast Cancer Stem CellsAn Integrative Approach to Precision Cancer Medicine Using Patient-Derived XenograftsCurrent State of Animal (Mouse) Modeling in Melanoma ResearchNeural Regulation of Pancreatic Cancer: A Novel Target for InterventionProspects and pitfalls of personalizing therapies for sarcomas: from children, adolescents, and young adults to the elderlyPatient-derived xenograft models of breast cancer and their predictive powerInfluence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenograftsPatient-derived xenografts: a relevant preclinical model for drug developmentImproving systemic breast cancer therapy: time to look beyond the primary tumour?Patient-derived tumour xenografts for breast cancer drug discoveryOrganoid development in cancer genome discoveryPrioritizing therapeutic targets using patient-derived xenograft modelsFrom bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?A phenotypic mouse model of basaloid breast tumorsDevelopment and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinomaTranslational validation of personalized treatment strategy based on genetic characteristics of glioblastomaCharacterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage PolarizationA Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer CompoundsUsing heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerClinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimensTumor microenvironment complexity: emerging roles in cancer therapy.Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Next-generation sequence analysis of cancer xenograft models.A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis.Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cellsDevelopment of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.The future of patient-derived tumor xenografts in cancer treatment.In vivo models in breast cancer research: progress, challenges and future directions.Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers.Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population.Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells.
P2860
Q24300043-156B2C59-EDDC-4DD4-969F-455B3810DFACQ24604068-6F31C986-5BD8-4C78-BA5C-66BD57D65AD5Q24621116-A6BFDAC2-877D-4E29-9A39-1D7BC9A7DC09Q24627425-B0EC39EA-CC7E-445A-A1C7-3A4ADD40ACF0Q26741651-5CA1682E-B661-4D27-AD4F-29FED4A2A6ABQ26746524-F0FB2ED4-D4ED-4F75-839E-67F477362358Q26765380-876582BC-9B68-4815-A04C-D8B775A5E162Q26767210-EB8656AD-C63B-401F-BB54-F0AD3068A75EQ26770495-FB010C02-0041-4082-824E-F1E5846A8048Q26771792-94337BAF-FC46-4408-8CDA-1E430AB704FDQ26772895-FDEC5E94-B8D5-4BBA-B852-8FCB9689B8F1Q26781652-B25CBD9C-802C-4B06-A89A-7E6EBA2D1170Q26801748-33A94371-DE50-4DBA-9C33-D9C6C828849AQ27025344-319C740A-B26B-4324-ACC1-3D477C57F247Q27026531-1D3E0C47-9C53-4513-AC55-E50E1F3AB374Q27321370-25D16229-74D1-4312-A0FB-F7B8E67A9BE6Q28067191-3AC8D356-A2A0-462D-8619-F67AD1C75E1EQ28078275-29E9829A-857D-4FB3-B79A-05697D575B00Q28080046-16C04FEA-55E4-4FCA-9230-189115398FA9Q28083032-E332DFC1-D09C-4F5D-9A24-0A7336A898CFQ28083993-1D63F014-55D1-478E-82E6-441D2E68A7D1Q28084982-F625398F-3CEC-4F45-A243-3B86603227EBQ28480588-78C2D156-1117-4424-BECE-91DF563FD2A9Q28534618-56FACB6B-84B5-425A-B960-4F90E43D8B63Q28541502-7348454E-7A24-4E83-B977-65D354C56A54Q28552410-8A327D4C-3FD5-4184-A390-1923A12CC476Q28598343-E977EA2C-1157-43E7-8F2E-84BF0EB2D5ADQ30409503-DBD37A47-1CA9-48FC-9DFD-40E82DD1BD32Q30416415-4AFA294C-9274-42D5-A6A7-90767B965CE5Q30419311-FFB11BC3-3708-4C38-A902-600989180942Q30423597-5293ACC7-F629-4ED0-9B65-674F7EAABEFAQ30448812-A722AACE-2CE7-48B0-B68A-4B8E262A9069Q30839218-32E6A676-42BA-41BF-B7C4-DA9501948481Q31123725-8A0B6F64-7EDA-41E7-A919-C0E27D81804DQ33275064-79FFC7B3-B07E-4A0A-AD1B-982BF70E7BDEQ33361578-1594781A-DD5C-4D2A-BC16-673878AB3F0AQ33588117-FAE0505C-C69F-4A83-BA4B-D304610C5285Q33626025-566253CE-447C-42AC-A736-1076757EE889Q33659361-BDB10927-A006-4D30-8E7F-2FB101D3D607Q33709971-5DF5DA42-F57E-4CDE-B934-D457B1067A6B
P2860
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tumor grafts derived from wome ...... etastasis and disease outcomes
@ast
Tumor grafts derived from wome ...... etastasis and disease outcomes
@en
Tumor grafts derived from wome ...... etastasis and disease outcomes
@nl
type
label
Tumor grafts derived from wome ...... etastasis and disease outcomes
@ast
Tumor grafts derived from wome ...... etastasis and disease outcomes
@en
Tumor grafts derived from wome ...... etastasis and disease outcomes
@nl
prefLabel
Tumor grafts derived from wome ...... etastasis and disease outcomes
@ast
Tumor grafts derived from wome ...... etastasis and disease outcomes
@en
Tumor grafts derived from wome ...... etastasis and disease outcomes
@nl
P2093
P2860
P3181
P356
P1433
P1476
Tumor grafts derived from wome ...... etastasis and disease outcomes
@en
P2093
Alana L Welm
Brett A Milash
Bryan E Welm
Edward Nelson
Guoying Wang
Inge J Stijleman
Leigh Neumayer
Philip S Bernard
R Lor Randall
Rachel Factor
P2860
P2888
P304
P3181
P356
10.1038/NM.2454
P407
P577
2011-10-23T00:00:00Z
P5875
P6179
1044243050